A science class captured Catherine Fahey’s imagination. A mother’s battle with cancer led her to pursue medicine as a career. At UNC, Fahey found a home at the junction of research and patient care.
When it comes to meeting the challenge of implementing new lung cancer screening guidelines, UNC is taking a multidisciplinary approach. Led by Daniel S. Reuland, MD MPH, Division of General Internal Medicine and Clinical Epidemiology, the UNC project on Supporting Appropriate Implementation of Lung cancer Screening (SAILS) is bringing together institutional experts as well as patient stakeholders to find ways to realize the benefits while minimizing the harms of the newly recommended screening test for lung cancer.
UNC Lineberger Comprehensive Cancer Center researchers and eight other leading cancer research institutions have won a five-year, $12 million grant to try to find treatments for a group of cancers linked to mutations in the NF1 gene.
Researchers from Norway visited the cancer center last week to learn firsthand about UNCseq, a clinical trial launched in 2011 at the N.C. Cancer Hospital. In the trial, researchers use a profile of the genetic and molecular alterations in patients' tumors to try to identify targeted treatments for them.
An $11.3 million, five-year grant from the National Cancer Institute will fund four studies by researchers with the Carolina Center of Cancer Nanotechnology Excellence.
A UNC Lineberger-led study, published today in Nature Genetics, paves the way for potential personalized medicine approaches for the deadly cancer type.
Fourteen-year-old star baseball player Liam Canard, of Raleigh, has been playing baseball throughout his battle with Hodgkin's lymphoma. Yesterday, thanks to Make-A-Wish of Eastern North Carolina, Liam received a gift that will help him hone his hitting while also taking his mind off his journey with cancer, and local media was there to cover it. View and read our wrap-up of media coverage, which includes Liam, his family, and pediatric hematologist-oncologist Dr. Patrick Thompson.
The editors of the MIT Technology Review highlighted Gu’s work on a novel way to monitor and treat diabetes.
In an article published in JAMA Oncology today, a study led by UNC Lineberger's Ethan Basch and colleagues shows that a system they developed accurately and reliably captures the patient experience with cancer drug side effects.
James Bear, PhD, uncovers the intricate mechanisms that allow certain cells to move, discoveries with implications for cancer metastasis.
Protecting the gastrointestinal system during chemotherapy or radiation could allow patients to tolerate more aggressive treatments to attack tumors.
Ten-year-old Ellie Stewart was diagnosed with choriocarcinoma in February. Her only plans for the summer were to finish her chemotherapy treatment at N.C. Children’s Hospital. Then she received a surprise gift: tickets to attend Taylor Swift’s June 9 concert in Raleigh. Now Ellie has some memories to help carry her through.
UNC’s Brian Strahl, PhD, and Van Andel Research Institute’s Scott Rothbart, PhD, create a robust online interactive database to address science’s ‘antibody crisis’.
High school dropout, Green Beret medic who served three tours in Iraq, Special Forces medic instructor at Fort Bragg, lymphoma fighter who is free of cancer today, and future physician and researcher -- the remarkable path to medicine of rising third-year UNC medical student Eric Strand.
Graduate student Sarah Shelton reinvented herself from a dancer to a scientist. Now, she’s creating a new ultrasound technique to improve cancer diagnostics.
A freshman professor when Michael Jordan was a first-year student-athlete, Keith Burridge, PhD, has dedicated his career to elucidating the intricate structures of cells that allow cancers to metastasize.
UNC Lineberger researchers are collaborating through the ClinGen consortium to pinpoint disease-causing genetic variants.
The latest installment in the Family House Diaries video series features Dr. Tom Shea, the Director and Founder of UNC's Bone Marrow Transplant Program, and Joe and Veatrice Harris of Roanoke Rapids, North Carolina.
Nearly a year ago, thirteen-year-old Liam Canard, of Raleigh, was diagnosed with Hodgkin’s lymphoma. Although his fight against the disease goes on today, he has already won by continuing to do what he loves.
A University of North Carolina at Chapel Hill analysis published today in the journal Tobacco Control synthesized the results of 37 different experiments comparing picture-based and text warnings, finding that picture-based warnings were more effective than text warnings on 20 of 25 different outcome measures.